Spinout acceleration.
Embedded support for a single spinout from IP to investable. Founder coaching, product strategy, team development and dual-purpose evidence outputs, all under one engagement.
9–18 months · embedded · co-author optionLed departments. Held grants. Shipped products that lasted. Coached academic founders into startup leaders.
We don't advise from the outside that we've not done from the inside.
The science is publishable. The technology works. But the gap between "we have IP" and "we have a venture that can survive in the market" is enormous, and it is a gap most internal university structures are not designed to close quickly.
Internal academic delivery carries high fixed costs, ethics-committee timelines, procurement processes and competing departmental priorities. For an innovation grant with a 12-month window, internal timelines frequently become the biggest risk to delivery. The expertise is real. The pace is the problem.
We bring academic-depth credentials, doctoral-level research, NIHR grant experience, without the institutional overhead. As an external consultancy we can move immediately on innovation funding. We've sat in every seat at the academic table, so we know how to work alongside your internal teams rather than against them.
Academic founders are trained to publish, to apply for grants, to peer-review. They are not trained to think about market positioning, product-market fit, commercial timelines or investor language. The transition from PI to CEO is a specific developmental challenge, and most TTOs have no dedicated resource to address it.
We've moved from academic research to commercial product, from grant holder to founder, from department lead to startup operator. We don't describe that transition theoretically. We coach it from lived experience, and we do it inside the grant timeline, not after it.
The things TTO directors and innovation-hub leads tell us they didn't expect, usually within the first month of an engagement.
Innovation grants frequently run to 12-month windows. Internal procurement, ethics-committee approval and departmental negotiation can consume three to six of those months before any work begins.
As an external consultancy we contract quickly, assemble the right team fast, and begin delivery immediately. We have moved from first conversation to active delivery within two weeks on live engagements. That speed is a structural advantage of working outside the university system while remaining academically credible alongside it.
As an external consultancy we can conduct market-validation research, user interviews, needs assessment and demand validation, without requiring ethical approval from your institution's committee.
For innovation projects that need fast market data to inform product direction, this removes one of the most common timeline blockers entirely. Where retrospective secondary-data analysis is needed, we build ethics frameworks in, with the university named as research partner. Rigour when you need it, speed when you don't.
On research rigour: we don't trade speed for credibility. Our market-validation methodology is documented, structured and producible as evidence for grant reporting, investor due diligence or REF impact case studies. Where peer-reviewed academic outputs are required, we co-author them, built into the engagement, not bolted on at the end.
Group Works had been trying to move their digital innovation forward for a number of years.
Within four months of engaging UXC, the picture had changed completely.
A digital innovation that had not progressed to market despite several years of founder effort
Engaged UXC to accelerate from idea to validated product, with the academic team coached to inherit the venture as startup leaders with a commercial edge.
All of the ingredients were there, we just added the secret sauce!
Market validation complete.
First release in build.
Full launch: September 2026.
UXC embedded. Founder diagnostic and product-hypothesis review completed. A clear picture of what had been blocking progress.
First working version built and tested. Market-validation research conducted, no ethics delay as an external consultancy.
Validation data informing the first full release. Academic team being coached into startup leadership and market positioning.
Complete product ready for market entry. Team equipped with commercial strategy, startup mindset and an investor-ready narrative.
Testimonial from Group Works and Bournemouth University available on request.
Talk to us about a similar engagement →The same network we assemble around a spinout, mobilised at national scale, when it mattered most.
When COVID hit, we led our whole network, psychologists, coaches and technologists, into a free wellbeing service for NHS staff. No budget. No commissioning cycle. Six weeks from idea to live, then sustained for years and delivered entirely by volunteers. It is the clearest proof of what this network can assemble and lead, fast, when it matters.
Three stages designed for the way university IP actually moves to market, and the way academic founders actually become CEOs. Iterative, not waterfall.
"What's actually here?"
IP-to-product mapping. Academic-founder readiness assessment. Team-stage diagnostic. An honest read on commercial viability and the development the team needs.
"Translate, build, lead."
Founder coaching for academic leads. Translation work, turning research into product strategy and investor language. Team development as the spinout takes shape.
"Publishable AND fundable."
Evaluation that produces academic-grade evidence and investor-grade traction proof. REF-eligible, grant-eligible, board-ready, same body of work, presented for different audiences.
REF-eligible academic outputs and investor-grade traction proof, generated from the same engagement. This is the part most consultancies can't do, and most TTOs need.
Mixed-methods evaluation written for the journal that fits the work. Co-authorship with the academic team, built into the contract, not bolted on at the end.
The same evaluation, restructured around the questions investors actually ask: adherence, unit economics, deployment risk, founder readiness. One report, two narratives.
From single-spinout acceleration to long-term hub partnerships. Each shape has a clear length, cadence and output, pricing is bespoke and shared in the discovery call.
Embedded support for a single spinout from IP to investable. Founder coaching, product strategy, team development and dual-purpose evidence outputs, all under one engagement.
9–18 months · embedded · co-author optionAccelerator programme for academic founders pre-spinout. Builds founder capability before the venture decision is made.
12 weeks · cohort of 6–81:1 coaching for the academic-to-CEO transition. Doctoral-depth, sprint-cadenced, fitted around teaching and lab life.
3–6 months · fortnightlyLong-term partnership with an innovation hub or TTO, UXC as the founder-development arm of the hub.
12–36 months · multi-spinoutCo-authored peer-reviewed work coming out of accelerator engagements. Publishable outputs, written together, REF-eligible.
Add-on · 6–12 monthsThings within my value set and my experience were acting as barriers to me being a more effective leader. After two sessions, I feel like I'm on a road to working through things that would definitely make me more effective.
Pulled from interviews and end-of-programme evaluations across our accelerator and coaching work. Names withheld; roles and context preserved.
For me I've just seen that I can achieve way more than I gave myself credit for to begin with.
I feel more positive that we can face the challenges of the future by being adaptable and using novel resources. I'm not sure that without the support we'd have had the confidence to use them to their fullest extent.
It enabled me to think more deeply about working relationships and how to be better. It was challenging, but also refreshing.
There could be a lot of hidden potential within a team that wouldn't be realised without some coaching.
This is what co-authorship looks like when it is built into the work. Peer-reviewed outputs developed alongside the clinicians, academics and partner organisations on the receiving end of the technology, so the same body of work serves REF impact, grant renewal and investor due diligence at once. Spans SUDEP and epilepsy risk, dementia screening, online-consultation workload and digital-health methods.
We'll listen, ask the questions a TTO and a founder both need answered, and either propose something or point you elsewhere. Discovery calls are free; written reads are sent within 48 hours regardless of fit.
Mapping a grant methodology, preparing a board case, or building an internal proposal? 90 minutes with both founders, and a two-page written report you can put in front of a committee.